Clinical significance of pretreatment serum C-reactive protein level in soft tissue sarcoma
β Scribed by Tomoki Nakamura; Akihiko Matsumine; Takao Matsubara; Kunihiro Asanuma; Astumasa Uchida; Akihiro Sudo
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 820 KB
- Volume
- 118
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Paraneoplastic syndromes (PNSs) associated with mesenchymal tumors are uncommon. Previous reports sporadically described inflammatory PNSs with elevated serum Cβreactive protein (CRP) levels and leukocytosis in patients with inflammatory malignant fibrous histiocytoma (MFH) of soft tiss
## Background: In chronic hemodialysis (hd) patients, the repetitive induction of the acute phase response (apr) may induce a chronic micro-inflammatory state, leading to various long-term complications. ## Methods: The present prospective study was designed to assess the alterations in the apr i
## Abstract ## BACKGROUND. The efficacy of palliative chemotherapy was investigated in a large group of patients with advanced softβtissue sarcomas (STS) treated on routine palliative protocols. ## METHODS. Patients with STS who had firstβline chemotherapy for advanced and/or metastatic disease
Background: Patients with clinically active Crohn's disease (CD), defined by a Crohn's Disease Activity Index (CDAI) ΟΎ150, may have normal C-reactive protein (CRP) serum levels. In such cases, it is difficult to know whether these patients have really active disease or rather functional symptoms. Th